论文部分内容阅读
目的研究丁苯酞与血栓通联合治疗缺血性脑卒中的临床效果。方法 84例缺血性脑卒中患者,随机分为对照组和治疗组,每组42例。对照组采用丁苯酞治疗,治疗组采用丁苯酞联合血栓通治疗。对比两组临床效果。结果治疗组患者治疗时间和神经功能恢复正常时间明显短于对照组,治疗总有效率明显高于对照组,用药治疗期间出现的不良反应明显少于对照组,用药前后韦氏记忆量表(WMS)和蒙特利尔认知评估量表(Mo CA)评分的改善程度明显大于对照组,差异均具有统计学意义(P<0.05)。结论丁苯酞与血栓通联合治疗缺血性脑卒中的临床效果非常明显,值得临床推广应用。
Objective To study the clinical effect of butylphthalide and Xueshuantong in treating ischemic stroke. Methods 84 patients with ischemic stroke were randomly divided into control group and treatment group, 42 cases in each group. The control group was treated with butylphthalide, and the treatment group was treated with butylphthalide and Xueshuantong. Compare the clinical effect of two groups. Results The treatment time and the recovery time of neurological function in the treatment group were significantly shorter than those in the control group, and the total effective rate was significantly higher than that in the control group. Adverse reactions were less in the treatment group than in the control group. Before and after treatment, the Wechsler Memory Scale ) And Montreal Cognitive Assessment Scale (MoCA) scores were significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion Butylphthalide and Xueshuantong combined treatment of ischemic stroke clinical effect is very obvious, worthy of clinical application.